FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, and represents a therapeutic composition in the form of an orally dispersed tablet for treating a pain syndrome in smooth muscle spasm characterised by the fact that it contains a combination of hyoscine butylbromide and a non-steroidal anti-inflammatory drug (NSAID) in the therapeutically effective amounts as active ingredients and pharmaceutically acceptable additives.
EFFECT: invention provides the higher efficacy and improved bioavailability of the active ingredient.
5 cl, 6 ex, 1 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG PREPARATION IN FORM OF ORALLY DISPERSIBLE TABLET AND METHOD FOR MAKING DRUG PREPARATION | 2012 |
|
RU2503447C1 |
| ORALLY DISINTEGRATING TABLET OF DEHYDROEPIANDROSTERONE AND/OR COMBINATION OF DEHYDROEPIANDROSTERONE AND L-THEANINE | 2014 |
|
RU2557960C1 |
| ORALLY DISPERSIBLE TABLET OF DEHYDROEPIANDROSTERONE | 2014 |
|
RU2545812C1 |
| COMBINATION FOR PREVENTION, CORRECTION AND THERAPY OF PAIN RELATED TO NEURODEGENERATION OR ASSOCIATED WITH SOMATOFORM DISORDERS | 2013 |
|
RU2506077C1 |
| COMBINATION IN ORAL DISPERSIBLE FORM WITH THERAPEUTIC ACTION ON ACTIVATING AND INHIBITORY FUNCTIONS OF NERVOUS SYSTEM (VERSIONS) | 2011 |
|
RU2464013C1 |
| NADH COMPOSITION HAVING ANTIOXIDANT PROPERTIES | 2014 |
|
RU2545920C1 |
| COMBINATION OF MIRTAZAPINE AND TIZANIDINE FOR USE IN PAIN DISORDERS | 2019 |
|
RU2736713C1 |
| NEW THERAPEUTIC COMBINATIONS OF MIRTAZAPINE APPLICABLE IN PAIN CONDITIONS | 2013 |
|
RU2509560C1 |
| COMBINATION OF FLUPIRTINE AND CYCLOBENZAPRINE FOR TREATMENT OF PAIN SYNDROMES | 2017 |
|
RU2680244C1 |
| BIOLOGIALLY ACTIVE AGENT HAVING EFFECT ON GENERAL METABOLIC, EXCITATORY AND INHIBITORY NERVE FUNCTION AND INTELLECTUAL MNESTIC CEREBRAL FUNCTIONS (VERSIONS) | 2011 |
|
RU2461374C1 |
